QCI Asset Management’s Peregrine Pharmaceuticals Inc. 10.50% Series E Convertible PPHMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-80
Closed -$2K 616
2018
Q1
$2K Hold
80
﹤0.01% 561
2017
Q4
$2K Buy
+80
New +$2K ﹤0.01% 575